Goldstein Neal S, Hewitt Stephen M, Taylor Clive R, Yaziji Hadi, Hicks David G
Department of Anatomic Pathology, William Beaumont Hospital, Royal Oak, MI 48073, USA.
Appl Immunohistochem Mol Morphol. 2007 Jun;15(2):124-33. doi: 10.1097/PAI.0b013e31804c7283.
Immunohistochemistry (IHC) continues to suffer from variable consistency, poor reproducibility, quality assurance disparities, and the lack of standardization resulting in poor concordance, validation, and verification. This document lists the recommendations made by the Ad-Hoc Committee on Immunohistochemistry Standardization to address these deficiencies. Contributing factors were established to be underfixation and irregular fixation, use of nonformalin fixatives and ancillary fixation procedures divested from a deep and full understanding of the IHC assay parameters, minimal or absent IHC assay optimization and validation procedures, and lack of a standard system of interpretation and reporting. Definitions and detailed guidelines pertaining to these areas are provided.
免疫组织化学(IHC)仍然存在一致性可变、可重复性差、质量保证差异以及缺乏标准化等问题,导致一致性、验证和核实性不佳。本文列出了免疫组织化学标准化特设委员会为解决这些缺陷而提出的建议。确定促成因素包括固定不足和固定不规律、使用非福尔马林固定剂以及从对免疫组织化学检测参数缺乏深入全面理解的辅助固定程序、免疫组织化学检测优化和验证程序极少或不存在,以及缺乏标准的解释和报告系统。文中提供了与这些领域相关的定义和详细指南。